Tema Oncology ETF (NASDAQ:CANC) Short Interest Down 67.6% in April

Tema Oncology ETF (NASDAQ:CANC) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totaling 8,604 shares, a decline of 67.6% from the April 15th total of 26,566 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily volume of 36,832 shares, the short-interest ratio is currently 0.2 days.

Institutional Trading of Tema Oncology ETF

Large investors have recently bought and sold shares of the business. Roxbury Financial LLC purchased a new stake in Tema Oncology ETF during the 1st quarter valued at about $34,000. LPL Financial LLC purchased a new stake in shares of Tema Oncology ETF in the 4th quarter valued at approximately $278,000. Jane Street Group LLC purchased a new stake in shares of Tema Oncology ETF in the 1st quarter valued at approximately $213,000. Flow Traders U.S. LLC purchased a new position in shares of Tema Oncology ETF in the 3rd quarter valued at $630,000. Finally, Thrivent Financial for Lutherans raised its position in Tema Oncology ETF by 891.1% during the fourth quarter. Thrivent Financial for Lutherans now owns 1,461,649 shares of the company’s stock worth $50,747,000 after acquiring an additional 1,314,177 shares during the last quarter.

Tema Oncology ETF Stock Performance

Shares of CANC stock traded down $0.26 on Thursday, reaching $37.86. 4,508 shares of the company were exchanged, compared to its average volume of 32,464. Tema Oncology ETF has a 1 year low of $22.48 and a 1 year high of $39.95. The company has a market cap of $177.56 million, a price-to-earnings ratio of 20.39 and a beta of 0.74. The business has a 50-day moving average price of $37.21 and a 200 day moving average price of $35.78.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.